InvestorsHub Logo
Followers 119
Posts 4512
Boards Moderated 2
Alias Born 04/14/2014

Re: JB3729 post# 59953

Saturday, 04/23/2016 6:49:50 PM

Saturday, April 23, 2016 6:49:50 PM

Post# of 459712
Prana is also Melbourne-based. Upping the ante in Macfarlane's potential COI. The study was poorly designed, and a comparison with our P2a reveals a clearer path to confirmation and the ability to fund and conduct a powerful P3.

Prana is currently offering DR for PBT2 in AD and it's Huntington's Disease indication is held-up by FDA pending neurotoxoligy studies to clear an acceptable dosage.

MPACs are a different ballpark than our s1 agonists.

NEWS FLASH!!!

Anavex 2-73 is NO LONGER AVAILABLE FROM TOCRIS BIOSCIENCE!!!!
https://www.tocris.com/404.php#.Vxv7BXoyM7V

This means the compound is either scrapped from development or licensed for it. Which do you think? big smile big smile big smile
§

Disclaimer

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News